与非典型抗精神病药物RISPERIDONE结合的多巴胺受体的结构
Sheng Wang1, Tao Che1, Anat Levit2
1Department of Pharmacology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina 27599-7365, USA.
研究人员发现了与RISPERIDONE结合的D2多巴胺受体 (DRD2) 的晶体结构. 这一发现揭示了一种新的药物结合机制,
科学领域:
- 神经科学
- 药理学
- 结构生物学
背景情况:
- 多巴胺是一种关键的神经递质, 调节各种功能, 包括奖励,运动和荷尔蒙分泌.
- 多巴胺信号的失调与神经和精神疾病如精神分裂症和帕金森病有关.
- D2多巴胺受体 (DRD2) 是治疗这些疾病的关键点,但目前的药物由于非点活性而引起副作用.
研究的目的:
- 阐明D2多巴胺受体 (DRD2) 的分子结构.
- 了解DRD2与非典型抗精神病药物RISPERIDONE之间的结合相互作用.
- 为设计更安全,更有效的DRD2向药物提供结构基础.
主要方法:
- 使用X射线结晶学来确定结构.
- 这项研究重点是DRD2与RISPERIDONE复合物.
主要成果:
- 成功确定了DRD2与RISPERIDONE复合的结晶结构.
- 发现了一种意想不到的抗精神病药物与多巴胺受体结合的模式.
- 确定了瑞斯佩里对DRD2作用的关键结构决定因素.
结论:
- 确定的DRD2-risperidone结构为合理的药物设计提供了一个分子模板.
- 了解这种结合相互作用可以指导开发具有更好的安全性和疗效的药物.
- 这种结构的洞察力对于治疗多巴胺相关疾病至关重要.
更多相关视频
10:19High-throughput Flow Cytometry Cell-based Assay to Detect Antibodies to N-Methyl-D-aspartate Receptor or Dopamine-2 Receptor in Human Serum
Published on: November 23, 2013
06:40Combined Infusion and Stimulation with Fast-Scan Cyclic Voltammetry CIS-FSCV to Assess Ventral Tegmental Area Receptor Regulation of Phasic Dopamine
Published on: April 23, 2020
相关概念视频
Antipsychotic Drugs: Typical and Atypical Agents
Drugs Affecting GI Tract Motility: Dopamine Receptor Antagonists
Psychosis and Antipsychotic Drugs: Overview
Antipsychotic Drugs: Therapeutic Uses and Side Effects
Despite these side effects, antipsychotics are used therapeutically for various purposes, including managing schizophrenia, preventing nausea and vomiting, curbing...
Drug-Receptor Bonds
In...
Drug-Receptor Interactions
Several parameters, such as the drug's affinity for its receptor and its efficacy, which is its ability to activate the receptor, determine the drug's effect on the tissue....
